Showing results (471-480 of 602) with videos related to
Sort By:
Pageof 61
The Prostate|August 17, 2021
The effect of primary urological cancers on survival in men with secondary prostate cancerMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.Frontiers in Oncology|October 25, 2021
The Effect of 10 Most Common Nonurological Primary Cancers on Survival in Men With Secondary Prostate CancerMike Wenzel, Luigi Nocera, Christoph Würnschimmel, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Memory activation reveals abnormal EEG in preclinical Huntington's diseaseKarin van der Hiele, Caroline K Jurgens, Alla A Vein, et al.Neuroimage. Clinical|November 2, 2013
Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approachHans-Peter Müller, Georg Grön, Reiner Sprengelmeyer, et al.Journal of the American Society of Nephrology : JASN|October 28, 2005
Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic valueMichael Eikmans, Marian C Roos-van Groningen, Yvo W J Sijpkens, et al.Cancer Immunology, Immunotherapy : CII|November 25, 2003
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckDavid R Colnot, Jan C Roos, Remco de Bree, et al.Human Molecular Genetics|September 22, 2006
Cholinergic neuronal defect without cell loss in Huntington's diseaseRuben Smith, Hinfan Chung, Sara Rundquist, et al.Plos One|May 24, 2018
Does arterial hypertension influence the onset of Huntington's disease?Leire Valcárcel-Ocete, Asier Fullaondo, Gorka Alkorta-Aranburu, et al.JACC. Clinical Electrophysiology|December 28, 2020
Conduction Heterogeneity: Impact of Underlying Heart Disease and Atrial FibrillationAnnejet Heida, Willemijn F B van der Does, Lianne N van Staveren, et al.Frontiers in Oncology|October 27, 2022
An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinomaMike Wenzel, Benedikt Hoeh, Jessica Rührup, et al.Pageof 61